LifeOmic, a software company that leverages the cloud, machine learning and mobile devices to power health and wellness solutions, has acquired Bavard, an AI-based start-up.
The purchase comes as AI technology has experienced widespread adoption in the health care space, a trend accelerated by the COVID-19 pandemic, LifeOmic said.
Bavard offers a “conversational AI platform that integrates seamlessly with an organisation’s platforms to deliver more personalised experiences”.
LifeOmic customers are now able to access AI-enabled customer support via a chat bot on the website or within the LIFE mobile applications.
Utilising advanced natural language processing, LifeOmic users can communicate with the platform in any language and receive a custom experience based on past interactions.
“Our customers are our number one priority, and this acquisition ensures we’re able to offer the best support possible,” said Dr. Don Brown, LifeOmic CEO and founder.
“They can now engage with a platform that responds 24/7 and is powered by thousands of data points to provide personalised suggestions when they need it most.”
LifeOmic’s digital health tools are used by employers, consumers and health care organisations to improve health outcomes.
Angelique Brown, Bavard CEO and co-founder said: “The majority of people are spending more time online and the need to optimise the experience is greater than ever. We created Bavard’s conversational platform to engage with users around the clock, even after a live support team has gone home.
“Together with LifeOmic, we are excited to leverage this cutting-edge technology in the health and wellness industry to help organisations deliver better user experiences at scale.”
